Services Provided by Lambda: Study design Clinical conduct Protocol development PK Sampling Safety lab evaluations Bioanalysis Pharmacokinetic and Biostatistical analysis CSR preparation and Report Compilation Study Execution Overview Sample Size: 60 healthy adult subjects (Male and Female) 60 healthy adult subjects (Male and Female) Study Duration & Visits ~5 weeks study duration, with multiple outpatient visits for PK sampling ~5 weeks study duration, with multiple outpatient visits for PK sampling Key Safety Measures Implemented (in addition to routine safety parameters) In addition to standard laboratory assessments at screening, specific safety parameters serum lipase and amylase were also evaluated
What GLP-1 users crave and what they can no longer eat Reduced appetite is one of the most commonly reported effects of GLP-1 medications , but cravings don't always disappear entirely
GHRP-2 (Growth Hormone Releasing Peptide-2): Another potent GHS-R agonist
Waterman C, Cheng DM, Rojas-Silva P, Poulev A, Dreifus J, Lila MA, Raskin I
This page outlines expected milestones and when to follow up with your provider
Are Peptides Worth It for Heart Health